Foundations of Ketamine-Assisted Psychotherapy (KAP)
February 2026
This presentation provides an overview of the clinical indications, safety considerations, and evidence base for the use of ketamine in mental health treatment. It also examines primary administration routes and their impact on therapeutic context and client experience.
The session introduces key concepts and terminology related to ketamine-assisted psychotherapy (KAP), including the therapeutic alliance, preparation, dosing, integration, and the roles of both therapists and medical providers.
The webinar offers 1 CE credit. To access the CE course as well as other free trainings from Journey Clinical, users can sign up for their free education platformopens in new window.
Accessibility
We strive to provide an inclusive, accessible experience that enables all individuals to engage with our programming. Captioning is displayed on this webinar recording and a transcript is also available. If you require any other accommodations to fully engage with this webinar recording, please email Advertising.
This program offers CE credit.
Paid for by
This topical webinar for APA members is paid for by Journey Clinical. The content was created by Journey Clinical and does not reflect the views of APA or its editorial staff. Email Advertising to learn more. Journey Clinical is the leading care-delivery platform and marketplace for FDA-approved psychedelic-assisted psychotherapy, expanding access to the next generation of evidence-based mental health treatments.
Speakers
Jessica Punzo, PsyD
A licensed clinical psychologist and PSYPACT provider with advanced training and leadership in trauma-focused care. She holds a doctoral degree in clinical psychology with a concentration in traumatic stress from Adler University and currently serves as past president of Division 56, Trauma Psychology, of APA.
Punzo has extensive experience treating PTSD and complex trauma across diverse clinical settings, including community mental health, corrections, and VA systems.
Brigitte Gordon, DNP, PMHNP-BC
A doctoral-trained, board-certified psychiatric nurse practitioner specializing in adult and geriatric psychiatric medication management and psychotherapy, with a subspecialty in integrative psychiatry. As lead clinician at Journey Clinical, she oversees and supports clinicians nationwide in delivering safe, effective, and compassionate ketamine-assisted psychotherapy.
Gordon also serves as an assistant professor in the doctoral program at Columbia University School of Nursing and continues her academic work as a researcher with the Multidisciplinary Association of Psychedelic Studies.